Quinazoline

Quinazoline

SCHEMBL11972093

c1ccc2[nH]cnc2c1.c1ccc2ncncc2c1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.67
PIK3CD O00329 1/20 0.46
PIK3CA P42336 1/20 0.46
TDO2 P48775 2/20 0.46
QPCT Q16769 1/20 0.39
QPCTL Q9NXS2 1/20 0.39
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
GAA P10253 2/20 0.36
GLA P06280 1/20 0.36
HSD17B10 Q99714 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinazoline SCHEMBL760383 0.84 EGFR (0.62) EGFRPIK3CDPIK3CATDO2KDM4E
Quinazoline SCHEMBL760382 0.82 EGFR (0.65) EGFRPIK3CDPIK3CATDO2KDM4E
Naphthalene SCHEMBL29363450 0.82 KDM4E (0.46) TDO2QPCTQPCTLKDM4EALDH1A1
Naphthalene SCHEMBL15819597 0.82 KDM4E (0.46) TDO2QPCTQPCTLKDM4EALDH1A1
Naphthalene SCHEMBL9738608 0.82 KDM4E (0.46) TDO2QPCTQPCTLKDM4EALDH1A1
Quinazoline SCHEMBL5920 0.82 EGFR (1.00) EGFRPIK3CDPIK3CATDO2KDM4E
Quinazoline SCHEMBL29490398 0.82 EGFR (1.00) EGFRPIK3CDPIK3CATDO2KDM4E
Quinazoline SCHEMBL22833783 0.82 EGFR (1.00) EGFRPIK3CDPIK3CATDO2KDM4E
Benzimidazole SCHEMBL28307511 0.82 KDM4E (0.48) TDO2QPCTQPCTLKDM4EALDH1A1
Quinazoline SCHEMBL29356169 0.82 EGFR (1.00) EGFRPIK3CDPIK3CATDO2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110615802-B Benzimidazole quinazoline derivative and preparation method and application thereof 江苏师范大学 2022-03-15 CN claimed
CN-110615802-A Benzimidazole quinazoline derivative and preparation method and application thereof 江苏师范大学 2019-12-27 CN claimed
CN-117976981-A Nonaqueous electrolyte and lithium ion battery 上海如鲲新材料股份有限公司 2024-05-03 CN disclosed
CN-116826175-B Wide-temperature-range non-aqueous electrolyte, lithium ion battery, battery module, battery pack and electricity utilization device 如鲲(江苏)新材料科技有限公司 2023-11-21 CN disclosed
CN-116315085-B Electrolyte additive, preparation method and application thereof 上海如鲲新材料股份有限公司 2023-10-10 CN disclosed
CN-116826175-A Wide-temperature-range non-aqueous electrolyte, lithium ion battery, battery module, battery pack and electricity utilization device 如鲲(江苏)新材料科技有限公司 2023-09-29 CN disclosed
CN-116332770-A Spiro compound and application thereof in organic photoelectric device 上海钥熠电子科技有限公司 2023-06-27 CN disclosed
CN-116284140-A Difluoro cyclic phosphate compound, preparation method and application thereof 上海如鲲新材料股份有限公司 2023-06-23 CN disclosed
CN-115863766-B Nonaqueous electrolyte and lithium ion battery 如鲲(江苏)新材料科技有限公司 2023-05-16 CN disclosed
CN-112010926-B KGH and hydroxymethyl modified benzimidazole quinazolines, synthesis, activity and applications thereof 首都医科大学 2022-04-22 CN disclosed
CN-112010926-B KGH and hydroxymethyl modified benzimidazole quinazolines, synthesis, activity and applications thereof 首都医科大学 2022-04-22 CN disclosed
CN-112010927-A EGH and hydroxymethyl modified benzimidazole quinazoline, and synthesis, activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-110615802-A Benzimidazole quinazoline derivative and preparation method and application thereof 江苏师范大学 2019-12-27 CN disclosed
CN-110615802-A Benzimidazole quinazoline derivative and preparation method and application thereof 江苏师范大学 2019-12-27 CN disclosed
CN-110615802-A Benzimidazole quinazoline derivative and preparation method and application thereof 江苏师范大学 2019-12-27 CN disclosed
CN-107629056-A Benzimidazole quinazoline Salicyloy lamino acid benzyl ester, its preparation, antitumor activity and application 首都医科大学 2018-01-26 CN disclosed
CN-107629056-A Benzimidazole quinazoline Salicyloy lamino acid benzyl ester, its preparation, antitumor activity and application 首都医科大学 2018-01-26 CN disclosed
US-9517977-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2016-12-13 US disclosed
CN-103153998-B Material for electronic devices 默克专利有限公司 2016-08-03 CN disclosed
US-20120211701-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120211701-A1 MATERIALS FOR ELECTRONIC DEVICES XPOT, ETV6, ERCC1 EGFR 1085/4885PIK3CD 3997/4885PIK3CA 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.